buy

Biocryst Pharmaceuticals buy Royal Bank of Canada

Biocryst Pharmaceuticals

Start price

€9.52

/ 50%

Target price

07.07.27

Performance (%)

Price

Summary

This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of . This prediction currently runs until 07.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction

Performance without dividends (%)

Name	1w
Biocryst Pharmaceuticals
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Royal_Bank_of_Canada for this prediction

In the thread Biocryst Pharmaceuticals diskutieren

Prediction Buy

Perf. (%)

Target price 12.240

Change

Ends at

BioCryst Pharmaceuticals (BCRX) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00. They now have an "outperform" rating on the stock.

Ratings data for BCRX provided by MarketBeat

Royal Bank of Canada